Definition/General

Introduction:
-Radiation colitis is iatrogenic inflammatory condition resulting from therapeutic radiation exposure
-Shows acute and chronic phases
-Dose-dependent injury with characteristic histologic changes
-Most common in pelvic radiation for gynecologic or prostate cancers.
Origin:
-Results from ionizing radiation damage to colonic tissues
-Causes DNA damage and free radical formation
-Shows endothelial injury and vascular damage
-Leads to fibroblast activation and chronic inflammation
-Progressive tissue injury over time.
Classification:
-Acute radiation colitis (within weeks of therapy)
-Chronic radiation colitis (months to years later)
-Early delayed effects (weeks to months)
-Late delayed effects (years)
-Radiation proctitis (rectal involvement).
Epidemiology:
-Common in patients receiving pelvic radiotherapy
-Dose-dependent incidence
-Higher risk with >45 Gy
-Age-related susceptibility
-Combined modality therapy increases risk
-Growing recognition with increased cancer survivorship.

Clinical Features

Presentation:
-Acute phase: diarrhea, urgency, tenesmus during radiation
-Chronic phase: rectal bleeding, strictures, obstruction months to years later
-Pelvic pain
-Fecal incontinence
-Weight loss.
Symptoms:
-Bloody diarrhea (most common chronic symptom)
-Urgency and frequency
-Tenesmus
-Abdominal cramping
-Mucus passage
-Iron deficiency anemia.
Risk Factors:
-Pelvic radiotherapy (gynecologic, prostate, rectal cancers)
-Radiation dose >45 Gy
-Large treatment volumes
-Advanced age
-Previous abdominal surgery
-Concurrent chemotherapy.
Screening:
-Colonoscopy (mucosal assessment)
-CT scan (complications)
-Barium studies (strictures)
-Clinical correlation with radiation history
-Exclude malignancy.

Master Radiation Colitis Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Acute phase: mucosal erythema, edema, superficial ulceration
-Chronic phase: pale, atrophic mucosa, telangiectasia, strictures
-Friable mucosa
-Loss of normal fold pattern
-Stenosis and adhesions.
Characteristics:
-Mucosal pallor
-Prominent telangiectasia
-Submucosal fibrosis
-Wall thickening
-Stenotic segments
-Easy bleeding
-Cobblestone appearance.
Size Location:
-Rectosigmoid (most common - pelvic radiation)
-Field-dependent distribution
-Sigmoid colon
-Small bowel involvement (ileum)
-Dose-gradient effects.
Multifocality:
-Radiation field distribution
-Dose-dependent severity
-Skip areas outside radiation field
-Progressive changes
-Late complications (strictures, fistulas).

Microscopic Description

Histological Features:
-Acute phase: mucosal necrosis, inflammation
-Chronic phase: atypical fibroblasts, vascular changes, fibrosis
-Bizarre stromal cells
-Telangiectasia
-Hyalinized blood vessels.
Cellular Characteristics:
-Atypical fibroblasts (enlarged, hyperchromatic nuclei)
-Bizarre stromal cells
-Radiation atypia in epithelium
-Endothelial swelling
-Foam cells
-Chronic inflammatory cells.
Architectural Patterns:
-Crypt distortion
-Surface ulceration
-Submucosal fibrosis
-Vascular sclerosis
-Smooth muscle atrophy
-Neural changes.
Grading Criteria:
-Acute: epithelial necrosis, acute inflammation
-Subacute: epithelial atypia, early fibrosis
-Chronic: fibrosis, vascular changes, atypical fibroblasts
-Severity correlates with dose and time.

Immunohistochemistry

Positive Markers:
-Smooth muscle actin (myofibroblasts)
-CD31 (endothelial cells)
-Factor VIII (endothelium)
-Cytokeratin (epithelium)
-p53 (may accumulate).
Negative Markers:
-Specific infectious agents
-Malignancy markers (unless carcinoma)
-IBD-associated markers
-Autoimmune markers.
Diagnostic Utility:
-Highlights vascular changes
-Demonstrates fibroblast activation
-Excludes malignancy
-Usually morphology sufficient
-p53 may show radiation-induced changes.
Molecular Subtypes:
-Acute radiation injury
-Chronic radiation injury
-Combined radiation-chemotherapy injury
-Dose-dependent patterns.

Molecular/Genetic

Genetic Mutations:
-TP53 mutations (radiation-induced)
-DNA repair gene defects
-Individual radiation sensitivity genes
-ATM gene variants
-BRCA gene associations.
Molecular Markers:
-DNA damage markers (γH2AX)
-Apoptosis markers
-Inflammatory mediators (TGF-β, TNF-α)
-Fibrosis markers (collagen, fibronectin)
-Vascular injury markers.
Prognostic Significance:
-Radiation dose (most important factor)
-Time since treatment
-Individual susceptibility
-Concurrent therapies
-Age at treatment.
Therapeutic Targets:
-Supportive care (anti-diarrheal, iron)
-Hyperbaric oxygen
-Sucralfate enemas
-Argon plasma coagulation (bleeding)
-Surgical intervention (complications).

Differential Diagnosis

Similar Entities:
-Inflammatory bowel disease
-Ischemic colitis
-Infectious colitis
-Drug-induced colitis
-Recurrent malignancy
-Anastomotic complications.
Distinguishing Features:
-Radiation colitis: Atypical fibroblasts, radiation history, field distribution
-IBD: Younger age, chronic architectural changes
-Ischemic: Watershed areas, acute onset
-Infectious: Organisms identified
-Malignancy: Dysplastic/malignant cells.
Diagnostic Challenges:
-Distinguishing from recurrent malignancy
-Recognizing radiation atypia vs dysplasia
-Correlating with radiation field
-Identifying late effects
-Clinical history essential.
Rare Variants:
-Acute radiation syndrome
-Radiation-induced malignancy
-Combined organ injury
-Fistula formation
-Perforation.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

[specimen type] from [anatomical location]

Radiation History

Radiation therapy: [yes - dose and dates]. Time since treatment: [duration]

Radiation Changes

Atypical fibroblasts: [present/absent]. Vascular changes: [telangiectasia/sclerosis]. Radiation atypia: [present/absent]

Fibrosis Assessment

Submucosal fibrosis: [mild/moderate/severe]. Smooth muscle changes: [present/absent]

Epithelial Changes

Surface ulceration: [present/absent]. Crypt distortion: [present/absent]. Epithelial atypia: [regenerative/radiation-induced]

Complications

Stricture formation: [present/absent]. Perforation: [present/absent]

Malignancy Assessment

No evidence of dysplasia or malignancy identified

Final Diagnosis

Radiation Colitis - [Acute/Chronic] radiation-induced changes